| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +2.43 M | 95.3% | $12.64 | +$30.7 M |
| Sells | 2 | -120 K | 4.7% | $11.85 | -$1.42 M |
| Net | -1 | +2.31 M | 90.6% | +$29.3 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | Director, 10%+ Owner | $83.7 M | +$30.7 M | +58% | Mar 4, 2024 |
| Orbimed Advisors Llc | 10%+ Owner | $21.1 M | Jan 25, 2022 | ||
| Rohan Palekar | Chief Executive Officer, Director | $5.01 M | -$1.18 M | -19.1% | Apr 1, 2024 |
| Quoc Le-Nguyen | Chief Technical Operations Officer and Head of Quality | $2.16 M | Feb 17, 2024 | ||
| Michael R. Hayden | Director | $1.64 M | Feb 1, 2024 | ||
| Harry H. Mansbach | Chief Medical Officer | $1.54 M | Feb 17, 2024 | ||
| Ryan Martins | Chief Financial Officer | $1.04 M | Feb 17, 2024 | ||
| Ram Waisbourd | Chief Operating Officer and Chief Business Officer | $101 K | Feb 17, 2022 | ||
| Gregory Grunberg | Director, 10%+ Owner | Feb 9, 2023 | |||
| Derek DiRocco | Director | Feb 1, 2024 | |||
| Edward Morrow Atkinson III | Director | Feb 1, 2024 | |||
| Laporte Kathleen | Director | -$235 K | Feb 1, 2024 | ||
| Steven Altschuler | Director | Feb 1, 2024 | |||
| Lota S. Zoth | Director | Feb 1, 2024 | |||
| Martin Babler | Director | May 2, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|